Navigation Links
New Generation Disinfecting Products to be Launched in Direct Sales Channel
Date:5/24/2010

DALLAS, May 24 /PRNewswire/ -- An innovative family of EPA-registered disinfecting products will be launched through a new direct selling company, it was announced today.

The first product, IV-7 Ultimate Germ Defense™, is a revolutionary, patented, broad-spectrum germ-killing treatment for hard surfaces.  It kills viruses, bacteria and fungi in as quickly as 30 seconds, using the first new disinfectant technology approved by the EPA in 30 years.

IV-7 has no odor or fumes, does not cause skin irritation, and creates an invisible barrier of protection that continues killing germs for 24 hours.  

It will be brought to the consumer market through a new direct selling company called IV-7 Direct, using a multi-level sales model.  Independent sales representatives will earn commissions selling the product and also from the sales of people who they enlist into the business.

John Rochon, former chairman of Mary Kay Inc. and a veteran of over 20 years in the direct selling industry, is heading IV-7 Direct, which is part of Dallas-based Richmont Holdings.  A related company, Richmont Sciences, is the sales and marketing arm of IV-7's manufacturer, Pure Biosciences of San Diego ( PURE).  

"We have an obligation to get this product into the war on germs as quickly as possible, to protect our loved ones and save lives," said Mr. Rochon.

"IV-7 is too special to put on store shelves.  Through the person-to-person contact of direct selling, we can show consumers how these products are different and spread the word quickly."  

"When I decided to return to the direct selling industry, I wanted to approach it in a new way.  I wanted a new business model that did two things:  First, get this product into the hands of millions of people quickly without a multi-million dollar advertising campaign; Second, give sellers a unique binary and unilevel compensation plan that can replenish the savings they've lost in the recession."

IV-7's patented formula is powered by silver dihydrogen citrate (SDC), which has been proven effective against viruses, bacteria and fungi including H1N1, MRSA, Salmonella, E. coli, Norovirus, Influenza A, VRE, Campylobachter jejuni, Staphylococcus aureus and other pathogens.  

PURE is developing additional uses for SDC in areas such as personal care products, pharmaceuticals and food processing.  Additional products will be added to the IV-7 Direct lineup.


'/>"/>
SOURCE IV-7 Direct
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Volcano Announces Positive Clinical Experience With Its Second Generation OCT Catheter, Prepares for U.S. Regulatory Study
2. Quantum move toward next generation computing
3. Haydon Kerk Motion Solutions Inspires Next Generation of Innovators as Silver Supplier of the FIRST Robotics Competition
4. Argonne to host next generation battery symposium May 3-4
5. Cerealus Announces Licensing Agreement for Bio-Based Ceregel™, A Next Generation Strength and Retention System
6. Ambry Genetics Launches First X-Linked Mental Retardation Diagnostics Using Next Generation Sequencing
7. OriGene Technologies Raises $16 Million to Build the Largest Collection of Next Generation Monoclonal Antibodies (TrueMAB(TM)) to Cover the Majority of Human Proteome
8. Acologix Presents Data on Cartilage Regeneration by AC-100 at the 56th Annual Meeting of the Orthopaedic Research Society
9. Caliper Life Sciences Launches LabChip(R) XT for Next Generation Sequencing Applications
10. GenomeQuest Announces Boston Seminar: Sequence Data Management for Next Generation Sequencing
11. Wellcome Trust Sanger Institute to use NEBNext(TM) DNA Sample Preparation Reagents from New England Biolabs for Next Generation Sequencing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... San Diego, CA (PRWEB) , ... May 20, 2016 , ... ... announce that 10 of its most experienced veterinary clients have treated over 100 of ... this cutting edge technology to provide the highest level of care for their patients. ...
(Date:5/19/2016)... ... May 19, 2016 , ... Anton Paar USA, located in ... office building is complete. The new structure adds a third office building to the ... USA purchased 2.4 acres of land, along with office space adjacent to the ...
(Date:5/19/2016)... May 19, 2016 ... (OTC PINK: RGBPP) announced today initiation of a ... cord blood based cancer immunotherapeutic product leveraging its ... Regen described a generation of cord blood derived ... gene silencing.  The product in development will be ...
(Date:5/18/2016)... YORK , May 18, 2016 ... but it does not mean that there are no opportunities ... Threshold Pharmaceuticals Inc. (NASDAQ: THLD ), Seattle Genetics ... CHMA ), and Ophthotech Corp. (NASDAQ: OPHT ... trading alerts at: http://www.activewallst.com/ ...
Breaking Biology Technology:
(Date:3/10/2016)... , March 10, 2016   Unisys Corporation (NYSE: ... Border Protection (CBP) is testing its biometric identity solution ... Diego to help identify certain non-U.S. citizens leaving ... The test, designed to help determine the efficiency and accuracy ... in February and will run until May 2016. --> ...
(Date:3/9/2016)... Germany , March 9, 2016 ... country,s government identified that more than 23,000 public service ... or had been receiving their salary unlawfully.    ... African country,s government identified that more than 23,000 public ... name or had been receiving their salary unlawfully.    ...
(Date:3/8/2016)... RALEIGH, N.C. , March 8, 2016 /PRNewswire/ ... biometric sensor technology, today announced it has secured ... led by GII Tech, a new venture fund ... LLC, with additional participation from existing investors TDF ... use the funds to continue its triple-digit growth ...
Breaking Biology News(10 mins):